Adherence to Bacille Calmette-Guerin protocol in the management of non-muscle invasive bladder cancer at St James’s Hospital

Key Points

• Adherence to Bacille Calmette-Guerin was suboptimal in non-muscle invasive bladder cancer treatment, which poses treatment challenges.
• Only 65% of patients followed the recommended Bacille Calmette-Guerin protocol during the treatment period observed over a year.
• The analysis utilized a retrospective cohort design assessing patient records at St James’s Hospital for adherence metrics.
• Improving adherence may enhance patient outcomes, highlighting the need for targeted interventions in cancer care.